Top Markets
#1 Wiki Cat Wiki Cat +38.93%
#2 Siren Siren +36.06%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.29%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.07%
#5 Velvet Velvet +17.46%
#6 KUB Coin KUB Coin +17.22%
#7 PulseChain PulseChain +17.12%
#8 aPriori aPriori +16.23%
#9 OpenEden OpenEden +15.08%
#10 The Grays Currency The Grays Currency +14.55%
Coin of the day
Wiki Cat Wiki Cat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Rangering i aksjer #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Aksjekurs
$0.01084256
Markedsverdi
$13.87M
Endring (1 dag)
0.00%
Endring (1 år)
1.70%
Land
NZ
Handel BLIS Technologies Limited (BLT)

Kategori

Healthcare
P/S-forhold for BLIS Technologies Limited (BLT)
P/S-forhold per 2026 TTM: 0
Ifølge BLIS Technologies Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for BLIS Technologies Limited fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE